VEGFA and retinopathy of prematurity: Hypoxia-induced upregulation of VEGF and the role of VEGF in exacerbating vascular proliferation in the vasoproliferative phase of ROP are well known and have led to the increasing use of anti-VEGF agents in ROP [5–7].